The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998
Open accessAbstract
A multicentre, collaborative study was performed in Asia and Europe during the winter of 1997-1998 to determine the in vitro activity of selected antimicrobial agents against common respiratory pathogens. Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolates were collected from 48 sites in China, France, Germany, Italy, Japan, Spain and the UK and tested in a central laboratory in the USA. Broth microdilution MICs were determined for beta-lactams (penicillin, amoxycillin/clavulanate, cefuroxime, ceftriaxone), macrolides (azithromycin, clarithromycin), sulphonamides (co-trimoxazole), glycopeptides (vancomycin) and fluoroquinolones (levofloxacin). The percentage of isolates susceptible to each antimicrobial class varied substantially by country. Penicillin susceptibility amongst pneumococci ranged from 34% in France and Spain to 92% in Germany, and macrolide susceptibility varied between 26% in China and 91% in the UK. In most countries beta-lactam, macrolide and cotrimoxazole resistance was more prevalent amongst penicillin-intermediate and -resistant S. pneumoniae isolates. However, little or no resistance was detected to levofloxacin (0.3% intermediate and resistant) or vancomycin (0% intermediate and resistant). For H. influenzae the prevalence of beta-lactamase production varied from 6% in China and Germany to 32% in Spain, and for M. catarrhalis, from 79% in Germany to 98% in Japan. With the exception of ampicillin, beta-lactamase production had a minimal effect on beta-lactam activity against H. influenzae or M. catarrhalis. Our findings demonstrate that antimicrobial resistance profiles of common respiratory isolates differ dramatically between countries in Asia and Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Bartlett, J. G., & Mundy, L. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332408 · Cited by 982
Emergence of Multiply Resistant Pneumococci
Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaäcson, M., Ward, J. I., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991402 · Cited by 630
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K., & Group, T. S. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1762 · Cited by 539
Hansman, D., & Bullen, M. M. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92346-x · Cited by 499
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Doern, G. V., Pfaller, M. A., Kugler, K., Freeman, J., & Jones, R. N. (1998) · Clinical Infectious Diseases · doi:10.1086/514953 · Cited by 386
Butler, J. C., Hofman, J., Cetron, M. S., Elliott, J. A., Facklam, R. R., Breiman, R. F., & Pneumococcal Sentinel Surveillance Working Group (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.986 · Cited by 341
Cited by
Clinical Practice Guideline (Update): Adult Sinusitis
Rosenfeld, R. M., Piccirillo, J. F., Chandrasekhar, S. S., Brook, I., Ashok Kumar, K., Kramper, M., Orlandi, R. R., Palmer, J. N., Patel, Z. M., Peters, A., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815572097 · Cited by 1,159
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Clinical practice guideline: Adult sinusitis
Rosenfeld, R. M., Andes, D., Neil, B., Cheung, D., Eisenberg, S., Ganiats, T. G., Gelzer, A., Hamilos, D., Haydon, R. C., Hudgins, P. A., et al. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2007.06.726 · Cited by 907
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Moraxella catarrhalis: from Emerging to Established Pathogen
Verduin, C. M., Hol, C., Fleer, A., van Dijk, H., & van Belkum, A. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.125-144.2002 · Cited by 353
Metadata
- Authors
- Thornsberry, C., Jones, M. E., Hickey, M. L., Mauriz, Y., Kahn, J., & Sahm, D. F.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12
- Volume
- 44
- Issue
- 6
- Pages
- 749-759
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2132279294
- Cited by
- 300
- References
- 27
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998. https://app.cochat.ai/papers/10.1093/jac/44.6.749
- The paper
- Thornsberry, C., Jones, M. E., Hickey, M. L., Mauriz, Y., Kahn, J., & Sahm, D. F. (1999). Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/44.6.749
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.